GG
TEVA icon

Gofen & Glossberg’s Teva Pharmaceuticals TEVA Stock Holding History

Gofen & Glossberg’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,884
Closed -$256K – 451
2018
Q3 		$256K Sell
11,884
-5,570
-32% -$129K 0.01% 393
2018
Q2 		$424K Sell
17,454
-200
-1% -$4.08K 0.02% 303
2018
Q1 		$302K Sell
17,654
-150
-0.8% -$2.93K 0.01% 367
2017
Q4 		$337K Sell
17,804
-22,071
-55% -$332K 0.01% 365
2017
Q3 		$702K Sell
39,875
-27,776
-41% -$625K 0.03% 243
2017
Q2 		$2.25M Sell
67,651
-20,117
-23% -$623K 0.09% 162
2017
Q1 		$2.82M Sell
87,768
-63,026
-42% -$2.15M 0.11% 138
2016
Q4 		$5.47M Sell
150,794
-22,674
-13% -$905K 0.22% 97
2016
Q3 		$7.98M Sell
173,468
-4,000
-2% -$209K 0.33% 82
2016
Q2 		$8.91M Sell
177,468
-3,891
-2% -$207K 0.37% 79
2016
Q1 		$9.71M Sell
181,359
-7,190
-4% -$422K 0.41% 77
2015
Q4 		$12.4M Sell
188,549
-3,979
-2% -$246K 0.54% 60
2015
Q3 		$10.9M Sell
192,528
-7,880
-4% -$511K 0.49% 66
2015
Q2 		$11.8M Buy
200,408
+4,293
+2% +$265K 0.5% 61
2015
Q1 		$12.2M Sell
196,115
-6,574
-3% -$382K 0.53% 58
2014
Q4 		$11.7M Sell
202,689
-3,213
-2% -$179K 0.5% 65
2014
Q3 		$11.1M Sell
205,902
-15,569
-7% -$825K 0.49% 65
2014
Q2 		$11.6M Sell
221,471
-29,611
-12% -$1.51M 0.51% 60
2014
Q1 		$12.5M Sell
251,082
-28,948
-10% -$1.34M 0.58% 52
2013
Q4 		$11.2M Sell
280,030
-19,423
-6% -$765K 0.53% 59
2013
Q3 		$11.3M Sell
299,453
-27,768
-8% -$1.08M 0.58% 53
2013
Q2 		$12.8M Buy
+327,221
New +$12.7M 0.69% 44

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Gofen & Glossberg's TEVA Position: Q4 2018 in Review

Gofen & Glossberg sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 11,884 shares — an estimated $256K sold.

Gofen & Glossberg first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $12.8M in Q2 2013. 551 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • Gofen & Glossberg reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Gofen & Glossberg sold 11,884 Teva Pharmaceuticals shares in Q4 2018, an estimated $256K.
  • Gofen & Glossberg first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Gofen & Glossberg's Teva Pharmaceuticals position peaked at $12.8M in Q2 2013.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Gofen & Glossberg's 13F filing for Q4 2018, filed 15 Jan 2019.